Spyre Therapeutics, Inc. issued a press release via Exhibit 99.1 regarding its financial results. The filing is furnished under Item 2.02 and includes Item 9.01 for financial statements and exhibits.
Key takeaways
Press release issued regarding financial results
Exhibit 99.1: Press release by Spyre Therapeutics, Inc.